CRU-GLOBAL designs and generates study protocols based on client input and best practices. We can recommend appropriate trial designs ranging from simple single end point designs to more sophisticated Bayesian adaptive designs. We’ll develop clinical study plans and protocols and provide the knowledge and support that is required to best address your specific business goals. 

The process involves multiple stages of review and relies on the expertise of our clinical, data management and biostatistics teams. A protocol timeline is developed and closely adhered to so that our clients are aware of every step of the process, from protocol synopsis to final protocol approval.